Siel Olbrecht

4.2k total citations · 1 hit paper
13 papers, 502 citations indexed

About

Siel Olbrecht is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Siel Olbrecht has authored 13 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Reproductive Medicine and 5 papers in Molecular Biology. Recurrent topics in Siel Olbrecht's work include Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (4 papers) and Single-cell and spatial transcriptomics (3 papers). Siel Olbrecht is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (4 papers) and Single-cell and spatial transcriptomics (3 papers). Siel Olbrecht collaborates with scholars based in Belgium, United States and United Kingdom. Siel Olbrecht's co-authors include Ignace Vergote, Adriaan Vanderstichele, Diether Lambrechts, Denis Querleu, Philippe Morice, Iain A. McNeish, Jonathan A. Ledermann, C. Sessa, Nicoletta Colombo and Andreas du Bois and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Siel Olbrecht

12 papers receiving 499 citations

Hit Papers

ESMO–ESGO consensus conference recommendations on ovarian... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
    2019 259 citations Nicoletta Colombo, C. Sessa et al. International Journal of Gynecological Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siel Olbrecht Belgium 7 294 212 129 107 106 13 502
Ahmed El‐Balat Germany 10 166 0.6× 208 1.0× 118 0.9× 50 0.5× 74 0.7× 34 426
Lucia Musacchio Italy 15 203 0.7× 283 1.3× 151 1.2× 55 0.5× 96 0.9× 46 551
Ying L. Liu United States 14 135 0.5× 198 0.9× 104 0.8× 77 0.7× 124 1.2× 48 481
Josep M. del Campo Spain 10 261 0.9× 187 0.9× 131 1.0× 62 0.6× 51 0.5× 20 439
Ingirídur Skírnisdóttir Sweden 16 499 1.7× 234 1.1× 176 1.4× 77 0.7× 107 1.0× 26 682
Elisabeth Janschek Austria 10 200 0.7× 318 1.5× 123 1.0× 136 1.3× 205 1.9× 17 687
Andrew Embleton-Thirsk United Kingdom 9 318 1.1× 188 0.9× 107 0.8× 60 0.6× 38 0.4× 18 427
M. Lapresa Italy 10 294 1.0× 113 0.5× 69 0.5× 97 0.9× 44 0.4× 16 420
Michaela Bártů Czechia 11 125 0.4× 112 0.5× 132 1.0× 78 0.7× 60 0.6× 52 385
Jeffrey C. Goh Australia 11 167 0.6× 167 0.8× 109 0.8× 35 0.3× 39 0.4× 35 376

Countries citing papers authored by Siel Olbrecht

Since Specialization
Citations

This map shows the geographic impact of Siel Olbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siel Olbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siel Olbrecht more than expected).

Fields of papers citing papers by Siel Olbrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siel Olbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siel Olbrecht. The network helps show where Siel Olbrecht may publish in the future.

Co-authorship network of co-authors of Siel Olbrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Siel Olbrecht. A scholar is included among the top collaborators of Siel Olbrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siel Olbrecht. Siel Olbrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rompuy, Anne‐Sophie Van, Gloria Marquina, Siel Olbrecht, et al.. (2025). Single-cell profiling in ovarian germ cell and sex cord-stromal tumours. British Journal of Cancer. 132(12). 1110–1123.
2.
Bempt, Isabelle Vanden, Anne‐Sophie Van Rompuy, Thaïs Baert, et al.. (2024). 1200 The significance of CTNNB1 mutation in endometrial cancer. Lirias (KU Leuven). A48.2–A49. 1 indexed citations
3.
Busschaert, Pieter, Siel Olbrecht, Liselore Loverix, et al.. (2022). 2022-RA-1136-ESGO A single-cell map of rare ovarian cancer. International Journal of Gynecological Cancer. 32. A412–A413. 2 indexed citations
4.
Bono, Johann S. de, Jeffrey R. Harris, Saskia M. Burm, et al.. (2022). Systematic study of tissue factor expression in solid tumors. Cancer Reports. 6(2). e1699–e1699. 19 indexed citations
5.
Vanderstichele, Adriaan, Liselore Loverix, Els Van Nieuwenhuysen, et al.. (2022). Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer. Gynecologic Oncology. 165(1). 14–22. 19 indexed citations
6.
Olbrecht, Siel, Pieter Busschaert, Jun Qian, et al.. (2021). High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Medicine. 13(1). 111–111. 109 indexed citations
7.
Vanderstichele, Adriaan, Liselore Loverix, Lien Heyrman, et al.. (2020). 817P Response to olaparib monotherapy in relapsed ovarian cancer by HRR gene mutational status and HRD scarring analysis: Results from the randomized phase II CLIO trial. Annals of Oncology. 31. S617–S618. 1 indexed citations
8.
Loverix, Liselore, Adriaan Vanderstichele, Siel Olbrecht, et al.. (2020). Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in platinum-sensitive recurrent ovarian cancer. Gynecologic Oncology. 159. 17–18. 3 indexed citations
9.
Colombo, Nicoletta, C. Sessa, Andreas du Bois, et al.. (2019). ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. International Journal of Gynecological Cancer. 29(4). 728–760. 259 indexed citations breakdown →
10.
Olbrecht, Siel, Lynn Jongen, Olivier Brouckaert, et al.. (2018). Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer. The Oncologist. 24(2). 165–171. 28 indexed citations
11.
Vanderstichele, Adriaan, Siel Olbrecht, & Ignace Vergote. (2018). Antiangiogenic therapies in ovarian cancer. memo - Magazine of European Medical Oncology. 11(1). 18–26. 2 indexed citations
12.
Vanderstichele, Adriaan, et al.. (2017). Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer. European Journal of Cancer. 86. 5–14. 49 indexed citations
13.
Olbrecht, Siel, Annouschka Laenen, Hans Wildiers, et al.. (2014). A Negative Progesterone Receptor in Luminal Her-2 Negative Breast Cancer by Age at Diagnosis: 10 Years Follow-Up. Annals of Oncology. 25. i8–i8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed El‐Balat Breakdown of academic impact, for papers by Lucia Musacchio Breakdown of academic impact, for papers by Ying L. Liu Breakdown of academic impact, for papers by Josep M. del Campo Breakdown of academic impact, for papers by Ingirídur Skírnisdóttir Breakdown of academic impact, for papers by Elisabeth Janschek Breakdown of academic impact, for papers by Andrew Embleton-Thirsk Breakdown of academic impact, for papers by M. Lapresa Breakdown of academic impact, for papers by Michaela Bártů Breakdown of academic impact, for papers by Jeffrey C. Goh
Rankless by CCL
2026